GTBP

GT BIOPHARMA INC

1 day chart

About GTBP

GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. TriKE platform generates therapeutics designed to harness and enhance the cancer killing abilities of a patients own natural killer cells (NK) cells. GTB-3550 is its TriKE product candidate which is a single-chain, tri-specific recombinant fusion protein construct composed of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15. The GTB-3550 Phase 1 clinical trial for treatment of patients with CD33-expression. It is also using its TriKE platform to develop therapeutics useful for the treatment of infectious disease, such as for the treatment of patients infected by the human immunodeficiency virus.

Buy US stocks in Australia starting with GTBP. Open an account and start investing today!

Market Capitalisation

$9.96M

Price-earnings ratio

Dividend yield

0.00%

Volume

81.18K

High today

$0.25

Low today

$0.25

Open price

$0.25

52-week high

$2.30

52-week low

$0.18

GTBP FAQs

Can I buy GTBP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy GTBP shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of GT BIOPHARMA INC?

One share of GT BIOPHARMA INC is valued at $0.27.

What is the ticker symbol for GT BIOPHARMA INC?

The ticker symbol for GT BIOPHARMA INC is GTBP.

How do I buy GTBP shares in Australia?

To buy GTBP stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in GTBP

What is the 52-week high for GT BIOPHARMA INC stock?

The GT BIOPHARMA INC 52-week high stock price is $2.30.

What is the 52-week low for GT BIOPHARMA INC stock?

The GT BIOPHARMA INC 52-week low stock price is $0.18.

What is the market capitalisation of GT BIOPHARMA INC GTBP?

As of 19/09/2023 GT BIOPHARMA INC has a market cap of $10M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.